A Study of SHR-A2102 in Combination With Other Anti-tumor Therapies for Resectable Non-small Cell Lung Cancer
Phase 2 · 1 site
Search the registry
2,585 studies found
Phase 2 · 1 site
Phase 1 / Phase 2 · 3 sites
Phase 2 / Phase 3 · 1 site
Potential match only. Final eligibility is determined by the study team.